CHICAGO, March 13, 2013 /PRNewswire-iReach/ -- Panasonic
Healthcare Company of North
America announced that a new independent study has found the
Panasonic H2O2 decontamination process to be very
effective for cell culture incubators, providing a complete
decontamination process in less than three hours. The independent
study, performed by Charles River Laboratories, tested the
effectiveness of H2O2 decontamination offered by the Panasonic
MCO-19 AIC Sterisonic® UVH cell culture incubator
against the industry leading brands with dry heat and moist heat
sterilization techniques.
The results of the study have been published in a Panasonic
white paper available at http://www.sterisonich2o2.com.
(Photo: http://photos.prnewswire.com/prnh/20130313/CG75713)
"The Panasonic MCO-19AIC UVH sets a new standard for advanced
sterilization and decontamination cycle time to return the
incubator to service significantly faster, allowing increased
productivity for researchers and clinicians in the research and
Good Manufacturing Practices (GMP) environments," said Deepak Mistry, Senior Manager, Strategic
Development and Marketing at Panasonic.
The study compared the Panasonic MCO-19AIC
Sterisonic® UVH cell culture incubator against two
models, one using dry heat sterilization and the other using moist
heat sterilization. While all the three incubators in the study
showed complete bioburden reduction of each organism tested,
Panasonic's incubator demonstrated an effective reduction of nearly
the same or, in some cases, a greater amount of bioburden in just 2
hours when compared to the 10-12 hour and 25 hour cycles required
by the other incubators, based upon the viability of the organisms
at room temperature over the elapsed sterilization times.
In an industry where both decontamination and equipment
operation time are critical, the Panasonic MCO-19AIC UVH has been
designed to stay up and running by offering shorter and equally
effective decontamination techniques. The incubator is suitable for
a wide array of demanding and highly regulated applications in the
biomedical, pharmaceutical, medical research and clinical
laboratory settings, representing years of research, development
and component testing. Prior to the independent test, the use of
H2O2 sterilization in biological safety cabinets and
barrier isolators was considered a popular alternative to ethylene
oxide (EtO), and viewed as a logical and safe method for
sterilization. Panasonic's incubator has a documented two-hour in
situ H2O2 sequence and features interior components with a CO2
sampling loop that are sterilized in situ with no additional need
for removal or separate autoclaving.
About Panasonic Healthcare Company of North America
Based in Secaucus, NJ, Panasonic
Healthcare Company of North
America is a division of Panasonic Corporation of
North America, the principal North
American subsidiary of Panasonic Corporation (NYSE:PC). The company
provides innovative technological solutions for the needs of
customers in the healthcare and life science markets. As a leader
in the technology industry, the company offers a wide range of
healthcare related products, as well as automation equipment for
pharmaceutical, biomedical, and other life science
applications.
For additional information, please visit
http://www.panasonic.com/business-solutions/healthcare-technology-solutions.asp
Editorial Contact
Dan
Unger
201-392-4571
dan.unger@us.panasonic.com
Media Contact: Aaron
Fowles, Panasonic Corporation of North America, 619-661-2223,
aaron.fowles@us.panasonic.com
News distributed by PR Newswire iReach:
https://ireach.prnewswire.com
SOURCE Panasonic Healthcare Company of North America